A framework for prescription in exercise-oncology research

John P Sasso, Neil D Eves, Jesper F Christensen, Graeme J Koelwyn, Jessica Scott, Lee W Jones, John P Sasso, Neil D Eves, Jesper F Christensen, Graeme J Koelwyn, Jessica Scott, Lee W Jones

Abstract

The field of exercise-oncology has increased dramatically over the past two decades, with close to 100 published studies investigating the efficacy of structured exercise training interventions in patients with cancer. Of interest, despite considerable differences in study population and primary study end point, the vast majority of studies have tested the efficacy of an exercise prescription that adhered to traditional guidelines consisting of either supervised or home-based endurance (aerobic) training or endurance training combined with resistance training, prescribed at a moderate intensity (50-75% of a predetermined physiological parameter, typically age-predicted heart rate maximum or reserve), for two to three sessions per week, for 10 to 60 min per exercise session, for 12 to 15 weeks. The use of generic exercise prescriptions may, however, be masking the full therapeutic potential of exercise treatment in the oncology setting. Against this background, this opinion paper provides an overview of the fundamental tenets of human exercise physiology known as the principles of training, with specific application of these principles in the design and conduct of clinical trials in exercise-oncology research. We contend that the application of these guidelines will ensure continued progress in the field while optimizing the safety and efficacy of exercise treatment following a cancer diagnosis.

© 2015 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society of Sarcopenia, Cachexia and Wasting Disorders.

Figures

Figure 1
Figure 1
The principles of training.
Figure 2
Figure 2
Oxygen consumption and ventilatory responses to incremental treadmill exercise in a 65 year-old woman with early-stage breast cancer. (A) Increasing workloads during the cardiopulmonary exercise test causes linear increases in oxygen consumption (VO2 in mL/kg/min) to the point of volitional fatigue at a VO2peak of 18.9 mL/kg/min. (B) A graphical representation of alveolar ventilation (VE in L/min) demonstrate two exponential ‘breakpoints’ in ventilation corresponding to Ventilatory Threshold 1 (VT1) and Ventilatory Threshold 2 (VT2). These thresholds demarcate the transition of low, medium, and high exercise intensity, and correspond to specific parameters that may be used for identification of relative intensity for exercise prescription and monitoring. These intensities and the corresponding ranges of physiological identification thereof (heart rate, blood pressure, and rating (Rtg) of perceived exertion on a 6–20 scale) provide an appropriate tool for indirect assessment of training stress and intensity.
Figure 3
Figure 3
Comparison of linear and nonlinear exercise prescriptions. Each bar represents a training session at prescribed workloads based on the absolute or relative intensity. (A) The conventional (linear) approach utilizes standard intensity, frequency, and duration parameters after an initial lead in period, with static increases in session duration (i.e. 20 to 45 min). (B) The alternative non-linear approach considers the principles of exercise training in order to optimize the adaptations to the exercise stimulus. Sessions are tailored to an individual's relative intensity, based on cardiopulmonary exercise testing or exercise tolerance testing, and specified to address a particular endpoint. Sessions and weeks progress over the course of the prescription and vary between low intensity (e.g. 55% VO2peak; white bars) and moderate (e.g. 75%; grey bars) and high intensity (e.g. 100% VO2peak; black bars) training in order to target various physiological systems involved in the cardiopulmonary response to exercise. Session intensity is inversely related to session duration, that is, sessions involving high relative intensity workloads are conducted in shorter bouts through short duration training sessions and are less frequent to ensure recovery between sessions. VO2peak, peak rate of oxygen consumption.

References

    1. Jones LW, Alfano CM. Exercise-oncology research: past, present, and future. Acta Oncol. 2013;52:195–215.
    1. Fong DY, Ho JW, Hui BP, Lee AM, Macfarlane DJ, Leung SS, et al. Physical activity for cancer survivors: meta-analysis of randomised controlled trials. BMJ. 2012;344:e70.
    1. Craft LL, Vaniterson EH, Helenowski IB, Rademaker AW, Courneya KS. Exercise effects on depressive symptoms in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol, Biomarkers Prev: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2012;21:3–19.
    1. McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ: Can Med Assoc J = Journal de l'Association medicale canadienne. 2006;175:34–41.
    1. Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G. Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. J Clin Oncol: official journal of the American Society of Clinical Oncology. 2005;23:3830–3842.
    1. Jones LW, Demark-Wahnefried W. Diet, exercise, and complementary therapies after primary treatment for cancer. Lancet Oncol. 2006;7:1017–1026.
    1. Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH. An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv: research Practice. 2010;4:87–100.
    1. Winters-Stone KM, Neil SE, Campbell KL. Attention to principles of exercise training: a review of exercise studies for survivors of cancers other than breast. Br J Sports Med. 2014;48:987–995.
    1. Campbell KL, Neil SE, Winters-Stone KM. Review of exercise studies in breast cancer survivors: attention to principles of exercise training. Br J Sports Med. 2012;46:909–916.
    1. Jones LW, Eves ND, Haykowsky M, Joy AA, Douglas PS. Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations. Lancet Oncol. 2008;9:757–765.
    1. American College of Sports M: American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc. 2009;41:687–708.
    1. Abernethy P, Wilson G, Logan P. Strength and power assessment. Issues, controversies and challenges. Sports Med. 1995;19:401–417.
    1. American Thoracic S. American College of Chest P: ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211–277.
    1. Kenjale AA, Hornsby WE, Crowgey T, Thomas S, Herndon JE, 2nd, Khouri MG, et al. Pre-exercise participation cardiovascular screening in a heterogeneous cohort of adult cancer patients. Oncologist. 2014;19:999–1005.
    1. Varray AL, Mercier JG, Terral CM, Prefaut CG. Individualized aerobic and high intensity training for asthmatic children in an exercise readaptation program. Is training always helpful for better adaptation to exercise? Chest. 1991;99:579–586.
    1. Vallet G, Ahmaidi S, Serres I, Fabre C, Bourgouin D, Desplan J, et al. Comparison of two training programmes in chronic airway limitation patients: standardized versus individualized protocols. Eur Respir J. 1997;10:114–122.
    1. Davis JA. Anaerobic threshold: review of the concept and directions for future research. Med Sci Sports Exerc. 1985;17:6–21.
    1. Hawley JA, Hargreaves M, Joyner MJ, Zierath JR. Integrative biology of exercise. Cell. 2014;159:738–749.
    1. Hawley JA. Adaptations of skeletal muscle to prolonged, intense endurance training. Clin Exp Pharmacol Physiol. 2002;29:218–222.
    1. Lakoski SG, Eves ND, Douglas PS, Jones LW. Exercise rehabilitation in patients with cancer. Nat Rev Clin Oncol. 2012;9:288–296.
    1. Convertino VA. Blood volume response to physical activity and inactivity. Am J Med Sci. 2007;334:72–79.
    1. Bishop DJ, Granata C, Eynon N. Can we optimise the exercise training prescription to maximise improvements in mitochondria function and content? Biochim Biophys Acta. 2014;1840:1266–1275.
    1. Roberts AD, Billeter R, Howald H. Anaerobic muscle enzyme changes after interval training. Int J Sports Med. 1982;3:18–21.
    1. MacDougall JD, Hicks AL, MacDonald JR, McKelvie RS, Green HJ, Smith KM. Muscle performance and enzymatic adaptations to sprint interval training. J Appl Physiol. 1985;84:2138–2142.
    1. Ristow M, Zarse K, Oberbach A, Kloting N, Birringer M, Kiehntopf M, et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci U S A. 2009;106:8665–8670.
    1. Hickson RC, Hagberg JM, Ehsani AA, Holloszy JO. Time course of the adaptive responses of aerobic power and heart rate to training. Med Sci Sports Exerc. 1981;13:17–20.
    1. Kreher JB, Schwartz JB. Overtraining syndrome: a practical guide. Sports Health. 2012;4:128–138.
    1. Saboul D, Balducci P, Millet G, Pialoux V, Hautier C. A pilot study on quantification of training load: The use of HRV in training practice. Eur J Sport Sci. 2015:1–10.
    1. Urhausen A, Kindermann W. Diagnosis of overtraining: what tools do we have? Sports Med. 2002;32:95–102.
    1. Hsia CC. Coordinated adaptation of oxygen transport in cardiopulmonary disease. Circulation. 2001;104:963–969.
    1. Fry RW, Morton AR, Keast D. Periodisation of training stress--a review. Can J Sport Sci. 1992;17:234–240.
    1. Fry RW, Morton AR, Keast D. Periodisation and the prevention of overtraining. Can J Sport Sci. 1992;17:241–248.
    1. Hellard P, Avalos M, Lacoste L, Barale F, Chatard JC, Millet GP. Assessing the limitations of the Banister model in monitoring training. J Sports Sci. 2006;24:509–520.
    1. Buffart LM, Galvao DA, Brug J, Chinapaw MJ, Newton RU. Evidence-based physical activity guidelines for cancer survivors: current guidelines, knowledge gaps and future research directions. Cancer Treat Rev. 2014;40:327–340.
    1. Fairbarn MS, Blackie SP, McElvaney NG, Wiggs BR, Pare PD, Pardy RL. Prediction of heart rate and oxygen uptake during incremental and maximal exercise in healthy adults. Chest. 1994;105:1365–1369.
    1. Panton LB, Graves JE, Pollock ML, Garzarella L, Carroll JF, Leggett SH, et al. Relative heart rate, heart rate reserve, and VO2 during submaximal exercise in the elderly. J Gerontol A Biol Sci Med Sci. 1996;51:M165–M171.
    1. Jones LW, Eves ND, Haykowsky M, Freedland SJ, Mackey JR. Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction. Lancet Oncol. 2009;10:598–605.
    1. Seiler KS, Kjerland GO. Quantifying training intensity distribution in elite endurance athletes: is there evidence for an ‘optimal’ distribution? Scand J Med Sci Sports. 2006;16:49–56.
    1. Orio F, Giallauria F, Palomba S, Manguso F, Orio M, Tafuri D, et al. Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women. Clin Endocrinol (Oxf) 2008;68:976–981.
    1. Saltin B, Blomqvist G, Mitchell JH, Johnson RL, Jr, Wildenthal K, Chapman CB. Response to exercise after bed rest and after training. Circulation. 1968;38:VII1–VII78.
    1. Rodon J, Saura C, Dienstmann R, Vivancos A, Ramon y Cajal S, Baselga J, et al. Molecular prescreening to select patient population in early clinical trials. Nat Rev Clin Oncol. 2012;9:359–366.
    1. Carden CP, Sarker D, Postel-Vinay S, Yap TA, Attard G, Banerji U, et al. Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development? Drug Discov Today. 2010;15:88–97.
    1. Klijn P, van Keimpema A, Legemaat M, Gosselink R, van Stel H. Nonlinear exercise training in advanced chronic obstructive pulmonary disease is superior to traditional exercise training. A randomized trial. Am J Respir Crit Care Med. 2013;188:193–200.
    1. Jones LW, Douglas PS, Eves ND, Marcom PK, Kraus WE, Herndon JE, 2nd, et al. Rationale and design of the Exercise Intensity Trial (EXCITE): a randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancer. BMC Cancer. 2010;10:531.
    1. Jones LW, Peddle CJ, Eves ND, Haykowsky MJ, Courneya KS, Mackey JR, et al. Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions. Cancer. 2007;110:590–598.
    1. Jones LW, Eves ND, Peterson BL, Garst J, Crawford J, West MJ, et al. Safety and feasibility of aerobic training on cardiopulmonary function and quality of life in postsurgical nonsmall cell lung cancer patients: a pilot study. Cancer. 2008;113:3430–3439.
    1. Courneya KS, Jones LW, Peddle CJ, Sellar CM, Reiman T, Joy AA, et al. Effects of aerobic exercise training in anemic cancer patients receiving darbepoetin alfa: a randomized controlled trial. Oncologist. 2008;13:1012–1020.
    1. Courneya KS, Sellar CM, Stevinson C, McNeely ML, Peddle CJ, Friedenreich CM, et al. Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J Clin Oncol. 2009;27:4605–4612.
    1. Hornsby WE, Douglas PS, West MJ, Kenjale AA, Lane AR, Schwitzer ER, et al. Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial. Acta Oncol. 2014;53:65–74.
    1. Jones LW, Hornsby WE, Freedland SJ, Lane A, West MJ, Moul JW, et al. Effects of nonlinear aerobic training on erectile dysfunction and cardiovascular function following radical prostatectomy for clinically localized prostate cancer. Eur Urol. 2014;65:852–855.

Source: PubMed

3
Abonneren